We have demonstrated that the ALS-associated R473 TBK1 mutation inhibits p62 and RIPK1 phosphorylation, leading to an RIPK1-mediated increase in IL-6 levels without altering the autophagic flux. This evidence concerns the gene RIPK1 and amyotrophic lateral sclerosis.